Unique ID issued by UMIN | UMIN000009900 |
---|---|
Receipt number | R000011595 |
Scientific Title | Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials. |
Date of disclosure of the study information | 2013/02/01 |
Last modified on | 2016/08/03 10:26:36 |
Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials.
Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials.
Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials.
Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials.
Japan |
postoperative abnormal behaviors such as agitation or restless in children undergoing general anesthesia
Anesthesiology |
Others
NO
To evaluate the effects of droperidol on postoperative abnormal behaviors such as agitation or restless in children undergoing general anesthesia.
Safety,Efficacy
The primary outcomes of this present meta-analysis are the incidence of postoperative abnormal behaviors such as agitation, restless, or extrapyramidal symptoms.
The secondary outcomes are the incidence of sedation.
Others,meta-analysis etc
Not applicable |
18 | years-old | > |
Male and Female
All randomized controlled trials comparing droperidol with any comparator (i.e., placebo, any drugs, or no treatment) administered during or before general anesthesia in children are included in this study. Eligibility is not restricted by language, type of surgery, or anesthetic technique.
We exclude studies which did not report our primary or secondary outcomes (i.e., postoperative abnormal behaviors such as agitation or restless, extrapyramidal symptoms, or sedation). We exclude studies which did not compare droperidol with any comparator (e.g., droperidol and midazolam vs. fentanyl), whereas we include studies "droperidol and drug A vs. drug A" because we can count the study as "droperidol vs. placebo". We also exclude data from abstracts, posters, case reports, comments or letters to the editor, reviews, and animal studies.
0
1st name | |
Middle name | |
Last name | Takahiro Mihara |
Yokohama City University Graduate School of Medicine
Department of Anesthesiology and Critical Care Medicine
3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
045-787-2918
miharaxxxtotoro@yahoo.co.jp
1st name | |
Middle name | |
Last name | Takahiro Mihara |
Yokohama City University Graduate School of Medicine
Department of Anesthesiology and Critical Care Medicine
2-138-4 Mutsukawa, Minami-ku, Yokohama 232-8555, Japan
045-711-2351
miharaxxxtotoro@yaoo.co.jp
Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine
None
Other
NO
2013 | Year | 02 | Month | 01 | Day |
Unpublished
Terminated
2013 | Year | 01 | Month | 29 | Day |
2013 | Year | 02 | Month | 01 | Day |
Design and search strategy
We search MEDLINE, CENTRAL, Embase, Web of Science, and ClinicalTrials.gov. up to February 1, 2013. In addition, the reference lists of the retrieved full articles are searched. Two authors independently scan the titles and abstracts of reports. If eligibility can not be determined from the title or abstract, the full paper is retrieved. Potentially relevant studies, chosen by at least one author, are retrieved and evaluated in full-text versions. The articles that met the inclusion criteria are assessed separately by two authors, and any discrepancies are resolved through discussion.
Data abstraction
A data collection sheet is created and include data on: (i) ASA-Physical Status, (ii) age, (iii) type of surgery, (iv) type of anesthesia, (v) route of administration of droperidol, (vi) timing of administration, (vii) dose of droperidol, (viii) type of control, (ix) number of incidence of PONV, number of incidence of postoperative abnormal behaviors such as (x) emergence agitation, (xi) other abnormal behaviors (e.g., restless), (xii) number of incidence of extrapyramidal symptoms, (xiii) number of incidence of sedation or (xiv) sedation time if reported, and (xv) primary outcome of the study. When abnormal behaviors were classified according to severity, we abstract the data of the number of incidence of abnormal behaviors from the most severe category. When multiple control groups including placebo group were made in individual studies, we choice the placebo group as a comparator group in this meta-analysis. Two authors extract the data independently from the studies included and then cross-check the data.
Risk of bias assessment
We assess the risk of bias as described by the Cochrane Handbook for Systematic Reviews of Interventions.
2013 | Year | 01 | Month | 30 | Day |
2016 | Year | 08 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011595